Director Bruce Downey to retire from Board, will not seek reelection at 2025 annual meeting
C4 Therapeutics, Inc.
Bruce Downey notified board of retirement effective after 2025 Annual Meeting of Stockholders.
Decision not due to any disagreement with company's strategy, operations, policies, or practices.
Will cease as chair and member of Organization, Leadership and Compensation Committee, Audit Committee, and Nominating and Corporate Governance Committee.
On April 10, 2025, Bruce Downey notified the Board of Directors (the “ Board ”) of C4 Therapeutics, Inc. (the “ Company ”) of his intention to retire from the Board and not to stand for reelection at the 2025 Annual Meeting of Stockholders.
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
Bruce Downey retired as Director at C4 Therapeutics, Inc..
Action
retired
Role
Director
Exact text from the filing
On April 10, 2025, Bruce Downey notified the Board of Directors (the “ Board ”) of C4 Therapeutics, Inc. (the “ Company ”) of his intention to retire from the Board and not to stand for reelection at the 2025 Annual Meeting of Stockholders.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.